Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Setting realistic expectations, attending regular follow-up appointments and making long-term lifestyle changes can help maximise the benefits of treatment while supporting lasting weight management
This weekly semaglutide injection is primarily used in adults with type 2 diabetes to improve blood sugar control, alongside diet and exercise
Its effects on appetite suppression reduce body weight, and significant weight loss effects kick in gradually but mostly appear from 3 months onwards with sustained reductions reaching far up beyond the 4 month mark even if usage remains constant throughout these periods, without further lower doses being required at any given point
Should the clinical trials go according to plan, Retatrutide should receive FDA approval in 2027, with an on-shelf date likely in 2029
US$ 26.93
US$ 25.76
US$ 27.20
US$ 27.72
